Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Shareholders??? Deficit

v3.24.1
Consolidated Statements of Changes in Shareholders’ Deficit - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interest
Total
Beginning Balance at Dec. 31, 2021 $ 282,217 $ 53,064,616 $ (57,515,129) $ 189,255 $ (3,979,041)
Beginning Balance (in Shares) at Dec. 31, 2021 282,216,632
Common stock issued for accounts payable $ 90 2,084 2,174
Common stock issued for accounts payable (in Shares) 90,859
Common stock issued for compensation $ 3,500 10,750 14,250
Common stock issued for compensation (in Shares) 3,500,000
Common stock issued for professional fees $ 17,954 199,296 217,250
Common stock issued for professional fees (in Shares) 17,954,545
Common stock issued for conversion of Series C preferred stock $ 21,263 117,737 139,000
Common stock issued for conversion of Series C preferred stock (in Shares) 21,262,973
Common stock issued in connection with debt $ 10,246 100,385 110,631
Common stock issued in connection with debt (in Shares) 10,245,163
Common stock issued as inducement to extend note payable $ 15,000 97,500 112,500
Common stock issued as inducement to extend note payable (in Shares) 15,000,000
Preferred stock dividends and deemed dividend 4,435 (60,090) (55,655)
Accretion of stock-based compensation 68,137 68,137
Relative fair value of warrants issued in connection with debt 325,785 325,785
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation 957,556 957,556
Beneficial conversion feature on convertible debt 354,215 354,215
Beneficial conversion feature buyback related to debt extinguishment (160,993) (160,993)
Net loss (income) (5,117,965) (38,513) (5,156,478)
Ending Balance at Dec. 31, 2022 $ 350,270 55,141,503 (62,693,184) 150,742 (7,050,669)
Ending Balance (in Shares) at Dec. 31, 2022 350,270,172
Common stock issued for cash and accrued compensation $ 54,545 245,455 300,000
Common stock issued for cash and accrued compensation (in Shares) 54,545,455
Common stock issued for compensation $ 2,500 23,500 26,000
Common stock issued for compensation (in Shares) 2,500,000
Common stock issued for professional fees $ 14,167 69,783 83,950
Common stock issued for professional fees (in Shares) 14,166,667
Common stock issued for accrued compensation $ 9,636 43,364 53,000
Common stock issued for accrued compensation (in Shares) 9,636,364
Common stock issued for conversion of Series C preferred stock $ 58,328 155,672 214,000
Common stock issued for conversion of Series C preferred stock (in Shares) 58,327,912
Common stock issued for conversion of debt, accrued interest and fees $ 43,372 157,017 200,389
Common stock issued for conversion of debt, accrued interest and fees (in Shares) 43,371,481
Preferred stock dividends and deemed dividend (54,195) (54,195)
Accretion of stock-based compensation 16,183 16,183
Net loss (income) 1,895,665 (8,858) 1,886,807
Ending Balance at Dec. 31, 2023 $ 532,818 $ 55,852,477 $ (60,851,714) $ 141,884 $ (4,324,535)
Ending Balance (in Shares) at Dec. 31, 2023 532,818,051